```html

Water‑melon Stomach (Gastric Antral Vascular Ectasia)

Overview

Water‑melon stomach, medically known as gastric antral vascular ectasia (GAVE), is a rare but clinically important cause of chronic gastrointestinal bleeding. The condition is characterized by dilated, tortuous blood vessels in the stomach’s antrum (the lower portion of the stomach) that appear as red, stripe‑like lesions resembling the flesh of a watermelon.

• Prevalence: GAVE accounts for approximately 4–5 % of non‑variceal upper gastrointestinal bleeding cases and is found in 0.4–4 % of patients undergoing endoscopy for obscure bleeding.<sup>1</sup>
• Typical age: Most patients are >60 years old; however, it can occur in younger adults with certain autoimmune diseases.
• Gender: Slight female predominance (approximately 55 % of cases).
• Population groups: Frequently associated with chronic liver disease, systemic sclerosis, and chronic kidney disease, but can also appear in otherwise healthy individuals.

Symptoms

Symptoms vary based on the amount of bleeding and may develop slowly over months or years. Common manifestations include:

• Occult gastrointestinal bleeding – positive fecal occult blood test without obvious visible blood.
• Iron‑deficiency anemia – fatigue, weakness, pallor, shortness of breath, or palpitations.
• Melena – black, tarry stools indicating digested blood.
• Hematemesis – vomiting fresh blood, less common but possible in severe cases.
• Abdominal discomfort – vague epigastric pain or fullness, often mistaken for dyspepsia.
• Weight loss – secondary to chronic anemia and reduced appetite.
• Syncope or dizziness – when blood loss is substantial enough to lower blood pressure.

Because the bleeding is usually slow, many patients are diagnosed only after routine blood work reveals low hemoglobin or after a “negative” endoscopy for ulcers or varices.

Causes and Risk Factors

Underlying Mechanisms

The exact cause of GAVE is not fully understood, but current research points to a combination of vascular, hormonal, and inflammatory pathways:

• Altered gastric motility: Chronic antral dysmotility may cause repeated trauma to the mucosal surface, prompting blood‑vessel dilation.
• Neuro‑humoral factors: Elevated levels of vasoactive peptides (e.g., gastrin, prostaglandins) and nitric oxide can weaken capillary walls.
• Autoimmune-mediated injury: In systemic sclerosis, immune complexes deposit in the gastric submucosa, leading to vessel ectasia.
• Portal hypertension: While GAVE differs from portal hypertensive gastropathy, the high‑pressure environment can exacerbate mucosal vascular changes.

Risk Factors

• Chronic liver disease (cirrhosis, hepatitis C) – reported in 30‑40 % of GAVE patients.<sup>2</sup>
• Systemic autoimmune disorders – especially limited cutaneous systemic sclerosis (CREST syndrome).<sup>3</sup>
• Chronic renal failure & hemodialysis.
• Use of non‑steroidal anti‑inflammatory drugs (NSAIDs) or aspirin – may aggravate mucosal irritation.
• Older age (>60 years) and female sex.
• History of gastric surgery or ulcer disease (less common).

Diagnosis

Because GAVE mimics other sources of upper GI bleeding, a systematic diagnostic approach is essential.

1. Clinical Evaluation

• Detailed medical history focusing on anemia symptoms, liver disease, autoimmune conditions, and medication use.
• Physical exam – look for signs of chronic liver disease (spider angiomas, palmar erythema) or systemic sclerosis (skin thickening, Raynaud’s).

2. Laboratory Tests

• Complete blood count – typically reveals microcytic, hypochromic anemia.
• Iron studies – low ferritin, low serum iron, high total iron‑binding capacity (TIBC).
• Liver function panel and renal profile – to assess comorbid disease.

3. Endoscopic Evaluation (Gold Standard)

An upper gastrointestinal endoscopy (esophagogastroduodenoscopy, EGD) is the definitive diagnostic tool.

• Endoscopic appearance: Parallel, longitudinal, reddish stripes radiating from the pylorus toward the body of the stomach; sometimes described as “water‑melon rind.”
• Biopsy of the lesions can confirm dilated capillaries, fibromuscular hyperplasia, and fibrin deposition, but is not mandatory if the classic pattern is seen.

4. Ancillary Imaging (when needed)

• Capsule endoscopy or double‑balloon enteroscopy: Helpful if bleeding persists despite normal EGD, to rule out small‑bowel sources.
• CT angiography: May be used in massive bleeding to locate active extravasation, though it rarely adds diagnostic value for GAVE.

Treatment Options

Treatment is individualized based on severity of bleeding, comorbidities, and patient preferences. The goals are to stop active bleeding, correct anemia, and prevent recurrence.

1. Medical Management

• Iron supplementation: Oral ferrous sulfate (325 mg × 1–3 times daily) or intravenous iron (e.g., iron sucrose) for patients intolerant to oral therapy or with refractory anemia.<sup>4</sup>
• Tranexamic acid: Short‑term oral therapy (1 g × 2–3 times daily) can reduce bleeding in selected cases.
• Hormonal therapy: High‑dose oral estrogen or progesterone (e.g., estrogen 0.5 mg daily) has been used historically but is less favored due to side‑effects.
• Octreotide: Somatostatin analogs (subcutaneous 50–100 µg 2–3 times daily) may reduce bleeding by decreasing splanchnic blood flow; evidence is limited.

2. Endoscopic Therapies (First‑line for active or recurrent bleeding)

• Argon plasma coagulation (APC): Non‑contact thermal method delivering ionized argon gas to coagulate superficial vessels. Used in 70–80 % of treated patients with good hemostasis and a mean reduction of transfusion requirements by 60 %.<sup>5</sup>
• Radiofrequency ablation (RFA): Balloon‑or‑probe‑based device that delivers controlled thermal injury; comparable efficacy to APC with fewer sessions in some series.
• Endoscopic band ligation (EBL): Primarily used for variceal bleeding but has shown success in isolated GAVE lesions when other methods fail.

3. Surgical Options (Rescue or refractory cases)

• Antrectomy (partial gastrectomy): Removal of the antral portion eliminates the diseased mucosa; indicated when endoscopic therapy fails and the patient can tolerate surgery. Reported cure rates >90 % but carries surgical risks.
• Transjugular intrahepatic portosystemic shunt (TIPS): Helpful in patients with concomitant portal hypertension; reduces overall portal pressure and may lessen GAVE bleeding.

4. Lifestyle & Supportive Measures

• Maintain adequate iron intake (red meat, legumes, fortified cereals).
• Avoid NSAIDs and aspirin unless prescribed with gastro‑protective agents.
• Limit alcohol intake, especially in patients with liver disease.
• Regular follow‑up endoscopy every 6–12 months for patients with a history of recurrent bleeding.

Living with Water‑melon Stomach (Gastric Antral Vascular Ectasia)

Managing GAVE is a long‑term commitment. Here are practical tips to help you stay healthy and reduce the need for medical interventions.

• Track your hemoglobin and iron levels: Schedule blood tests every 3–6 months, or more often if you notice new fatigue or black stools.
• Adopt a nutrient‑dense diet: Include vitamin C‑rich foods (citrus, berries) to enhance iron absorption. Pair iron‑rich meals with a source of vitamin C and avoid tea/coffee within an hour of the meal.
• Stay hydrated: Dehydration may concentrate gastric acid and aggravate mucosal irritation.
• Medication review: Have your pharmacist or physician review all over‑the‑counter drugs; consider switching to acetaminophen for pain relief if appropriate.
• Vaccinations: If you have chronic liver disease, stay up‑to‑date on hepatitis A/B, influenza, and pneumococcal vaccines.
• Activity level: Light to moderate exercise improves cardiovascular health and may help maintain healthy blood counts, but avoid high‑impact activities if you feel dizzy or faint.
• Support network: Join patient advocacy groups such as the American Liver Foundation or systemic sclerosis societies for emotional support and latest research updates.

Prevention

Because many risk factors (age, autoimmune disease, liver cirrhosis) cannot be changed, prevention focuses on modifiable contributors.

• Control chronic liver disease: abstain from alcohol, adhere to antiviral therapy for hepatitis B/C, and follow a low‑sodium diet to reduce portal pressure.
• Manage systemic sclerosis: keep skin tightness under control, use disease‑modifying agents as prescribed, and attend regular rheumatology appointments.
• Limit NSAID/aspirin use: when pain relief is needed, use the lowest effective dose with a proton‑pump inhibitor (PPI) for gastric protection.
• Routine screening for anemia in high‑risk groups (cirrhosis, dialysis patients) allows early detection before significant bleeding occurs.

Complications

If left untreated or inadequately managed, GAVE can lead to serious health problems:

• Severe iron‑deficiency anemia: May require repeated blood transfusions, increasing the risk of transfusion reactions and iron overload.
• Cardiovascular strain: Chronic anemia can cause tachycardia, high-output heart failure, and exacerbation of existing coronary disease.
• Hypovolemic shock: Rare but possible during massive bleeding episodes; presents with hypotension, rapid pulse, and altered mental status.
• Quality‑of‑life decline: Fatigue, weakness, and frequent hospital visits can limit daily activities and work productivity.
• Complications from treatment: Endoscopic thermal injury may cause gastric ulceration; surgery carries infection, bleeding, and nutritional deficiencies.

When to Seek Emergency Care

References

1. Mayo Clinic. Gastric Antral Vascular Ectasia (GAVE). Link. Accessed June 2026.
2. Cleveland Clinic. Gastric Antral Vascular Ectasia (GAVE). Link. Accessed June 2026.
3. Gastroenterology. Systemic sclerosis and gastrointestinal involvement. PMCID: PMC5672028. 2018.
4. NIH National Heart, Lung, and Blood Institute. Iron‑deficiency anemia. Link. Updated 2023.
5. Gastrointestinal Endoscopy. Argon plasma coagulation for GAVE: systematic review and meta‑analysis. Link. 2014.

```